MA27457A1 - Formulations de derive d'acide nodulisporique pour un traitement cutane localise contre les parasites. - Google Patents
Formulations de derive d'acide nodulisporique pour un traitement cutane localise contre les parasites.Info
- Publication number
- MA27457A1 MA27457A1 MA28236A MA28236A MA27457A1 MA 27457 A1 MA27457 A1 MA 27457A1 MA 28236 A MA28236 A MA 28236A MA 28236 A MA28236 A MA 28236A MA 27457 A1 MA27457 A1 MA 27457A1
- Authority
- MA
- Morocco
- Prior art keywords
- nodulisporic acid
- acid derivative
- skin treatment
- present
- treatment against
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 244000045947 parasite Species 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- UNCVXXVJJXJZII-QLETUHIQSA-N 1k1cu6363a Chemical class OC(=O)C(/C)=C/C=C/[C@@](C)([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@]1(C)[C@@H]2CC2=C1N1[C@@H](C(=C)C)C(=O)C3=C([C@@H](O)[C@@H]4C(OC(C)(C)C=C44)(C)C)C4=CC2=C31 UNCVXXVJJXJZII-QLETUHIQSA-N 0.000 title abstract 2
- 206010061217 Infestation Diseases 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- -1 amide derivatives of nodulisporic acid Chemical class 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Epidemiology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention propose, entre autres, des compositions pour dépôt destinées au traitement ou à la prophylaxie d'infestations par des parasites chez des mammifères ou des oiseaux qui comprend : (1) au moins un dérivé de l'acide nodulisporique ; (2) un véhicule vecteur liquide acceptable ; et (3) facultativement, un inhibiteur de cristallisation. L'invention propose également un procédé destiné au traitement d'infestations parasitaires ou à la prophylaxie d'infestation par des parasites chez des mammifères ou des oiseaux qui comprend appliquer de manière topique audit mammifère ou oiseau une quantité efficace d'une composition conformément à la présente invention. En outre, la présente invention se rapporte à un procédé d'amidification destiné à préparer des dérivés amide de l'acide nodulisporique et à l'intermédiaire formé dans ce procédé.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41562702P | 2002-10-02 | 2002-10-02 | |
| US10/618,975 US20040077703A1 (en) | 2002-10-02 | 2003-07-14 | Nodulisporic acid derivative spot-on formulations for combating parasites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27457A1 true MA27457A1 (fr) | 2005-07-01 |
Family
ID=32073382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28236A MA27457A1 (fr) | 2002-10-02 | 2005-04-25 | Formulations de derive d'acide nodulisporique pour un traitement cutane localise contre les parasites. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040077703A1 (fr) |
| EP (1) | EP1545211B1 (fr) |
| JP (1) | JP2006502241A (fr) |
| KR (2) | KR20070099668A (fr) |
| CN (1) | CN100496244C (fr) |
| AP (1) | AP2047A (fr) |
| AU (1) | AU2003279002A1 (fr) |
| BR (1) | BR0314531A (fr) |
| CA (1) | CA2500822C (fr) |
| CO (1) | CO5700750A2 (fr) |
| CR (2) | CR7810A (fr) |
| EA (1) | EA009683B1 (fr) |
| EC (1) | ECSP055736A (fr) |
| ES (1) | ES2482101T3 (fr) |
| GE (1) | GEP20084414B (fr) |
| MA (1) | MA27457A1 (fr) |
| MX (1) | MXPA05003581A (fr) |
| NZ (1) | NZ539227A (fr) |
| UA (1) | UA83199C2 (fr) |
| WO (1) | WO2004030457A1 (fr) |
| ZA (1) | ZA200502904B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9416065B2 (en) * | 2007-02-12 | 2016-08-16 | Archer Daniels Midland Company | Adjuvants and methods of using them |
| CA2706448C (fr) * | 2007-11-26 | 2016-08-16 | Merial Limited | Systemes de solvants pour solutions a application cutanee, utilisables dans le cadre de la lutte contre les parasites |
| EP2875726A1 (fr) | 2013-11-13 | 2015-05-27 | Ceva Animal Health | Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites |
| KR101687973B1 (ko) | 2015-12-08 | 2016-12-21 | 주식회사 씨티씨바이오 | 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법 |
| CN111542602B (zh) * | 2017-09-29 | 2025-03-11 | 维多利亚联结有限公司 | 多节孢酸(Nodulisporic acid)的异源生物合成 |
| KR102178885B1 (ko) * | 2020-01-17 | 2020-11-13 | 강현준 | 카프릴산을 포함하는 안정한 해충 방제제 및 이의 제조방법 |
| WO2026073866A1 (fr) | 2024-10-01 | 2026-04-09 | Syngenta Crop Protection Ag | Procédés de lutte contre des insectes de la famille des pentatomidae |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2753377B1 (fr) * | 1996-09-19 | 1999-09-24 | Rhone Merieux | Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides |
| US6426333B1 (en) * | 1996-09-19 | 2002-07-30 | Merial | Spot-on formulations for combating parasites |
| US3950360A (en) * | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
| JPS57139012A (en) * | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
| US4427663A (en) * | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
| EP0237482A1 (fr) * | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | Dérivés de la C(29)-carbonyloxy-milbémycine pour la lutte contre les parasites d'espèces végétales ou animales |
| EP0342710B1 (fr) * | 1986-03-25 | 1993-05-19 | Sankyo Company Limited | Dérivés du type macrolide, leur préparation et leur utilisation |
| GB8613914D0 (en) * | 1986-06-07 | 1986-07-09 | Coopers Animal Health | Liquid formulations |
| ATE75745T1 (de) * | 1986-07-02 | 1992-05-15 | Ciba Geigy Ag | Pestizide. |
| US4855317A (en) * | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
| US4871719A (en) * | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
| DE3888936T2 (de) * | 1987-11-03 | 1994-07-21 | Beecham Group Plc | Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung. |
| NZ232422A (en) * | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
| CA2036148A1 (fr) * | 1990-06-29 | 1991-12-30 | Hiroki Tomioka | Derive de 1-phenylimidazole ainsi que sa production et son utilisation |
| GB9205007D0 (en) * | 1992-03-07 | 1992-04-22 | Pfizer Ltd | Antiparasitic agents |
| GB9300883D0 (en) | 1993-01-18 | 1993-03-10 | Pfizer Ltd | Antiparasitic agents |
| EP0611774B1 (fr) * | 1993-02-19 | 1999-05-26 | F. Hoffmann-La Roche Ag | Production des amides et des peptides sans racemisation en présence de quantités catalytiques d'un composé N-hydroxylé |
| GB9315108D0 (en) * | 1993-07-21 | 1993-09-01 | Pfizer Ltd | Antiparasitic agents |
| US5399582A (en) * | 1993-11-01 | 1995-03-21 | Merck & Co., Inc. | Antiparasitic agents |
| GB9402916D0 (en) * | 1994-02-16 | 1994-04-06 | Pfizer Ltd | Antiparasitic agents |
| JPH0827018A (ja) * | 1994-07-22 | 1996-01-30 | Sanwa Kagaku Kenkyusho Co Ltd | 生理活性ペプチド又は蛋白質を含有する薬剤組成物 |
| AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
| US5595998A (en) * | 1994-12-15 | 1997-01-21 | Wolin; Ronald L. | Pyrazoloquinolines |
| PL185563B1 (pl) * | 1995-03-20 | 2003-06-30 | Merck & Co Inc | Pochodne kwasu nodulisporowego oraz zawierające je kompozycje farmaceutyczne |
| US6221894B1 (en) * | 1995-03-20 | 2001-04-24 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US5595991A (en) * | 1995-03-20 | 1997-01-21 | Merck & Co., Inc. | Anthelmintic use of nodulisporic acid and analogs thereof |
| US5962499A (en) * | 1995-03-20 | 1999-10-05 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| FR2739255B1 (fr) * | 1995-09-29 | 1998-09-04 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
| US6010710A (en) * | 1996-03-29 | 2000-01-04 | Merial | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
| IE80657B1 (en) * | 1996-03-29 | 1998-11-04 | Merial Sas | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs |
| US5885607A (en) * | 1996-03-29 | 1999-03-23 | Rhone Merieux | N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs |
| US5834260A (en) * | 1996-08-30 | 1998-11-10 | Merck & Co., Inc. | Antiparasitic agents |
| DE69720016T2 (de) * | 1996-09-19 | 2004-01-22 | Merck & Co., Inc. | Nodulisporinsäurederivate |
| US6136838A (en) * | 1998-03-19 | 2000-10-24 | Merck & Co., Inc. | Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations |
| ATE239701T1 (de) * | 1998-03-30 | 2003-05-15 | Lg Chemical Ltd | Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung |
| US6399796B2 (en) * | 2000-03-17 | 2002-06-04 | Roche Vitamins Inc. | Activation of a Diels-Alder reaction of a sterol 5,7-diene |
| US6399786B1 (en) * | 2000-07-14 | 2002-06-04 | Merck & Co., Inc. | Nonacyclic nodulisporic acid derivatives |
| US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| US20050234119A1 (en) * | 2004-04-16 | 2005-10-20 | Soll Mark D | Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals |
| US20080003282A1 (en) * | 2005-04-18 | 2008-01-03 | Soll Mark D | Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals |
-
2003
- 2003-07-14 US US10/618,975 patent/US20040077703A1/en not_active Abandoned
- 2003-09-29 NZ NZ539227A patent/NZ539227A/en not_active IP Right Cessation
- 2003-09-29 EA EA200500579A patent/EA009683B1/ru not_active IP Right Cessation
- 2003-09-29 CN CNB038253070A patent/CN100496244C/zh not_active Expired - Fee Related
- 2003-09-29 CA CA2500822A patent/CA2500822C/fr not_active Expired - Lifetime
- 2003-09-29 EP EP03770513.4A patent/EP1545211B1/fr not_active Expired - Lifetime
- 2003-09-29 WO PCT/US2003/030500 patent/WO2004030457A1/fr not_active Ceased
- 2003-09-29 AU AU2003279002A patent/AU2003279002A1/en not_active Abandoned
- 2003-09-29 AP AP2005003289A patent/AP2047A/xx active
- 2003-09-29 KR KR1020077019588A patent/KR20070099668A/ko not_active Withdrawn
- 2003-09-29 KR KR1020057005819A patent/KR20050059235A/ko not_active Ceased
- 2003-09-29 JP JP2005500323A patent/JP2006502241A/ja active Pending
- 2003-09-29 ES ES03770513.4T patent/ES2482101T3/es not_active Expired - Lifetime
- 2003-09-29 UA UAA200504055A patent/UA83199C2/ru unknown
- 2003-09-29 GE GEAP20038771A patent/GEP20084414B/en unknown
- 2003-09-29 BR BR0314531-0A patent/BR0314531A/pt not_active Application Discontinuation
- 2003-09-29 MX MXPA05003581A patent/MXPA05003581A/es unknown
-
2005
- 2005-04-11 ZA ZA200502904A patent/ZA200502904B/en unknown
- 2005-04-18 EC EC2005005736A patent/ECSP055736A/es unknown
- 2005-04-25 MA MA28236A patent/MA27457A1/fr unknown
- 2005-04-28 CO CO05040666A patent/CO5700750A2/es not_active Application Discontinuation
- 2005-04-28 CR CR7810A patent/CR7810A/es unknown
-
2008
- 2008-09-25 CR CR10319A patent/CR10319A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2500822A1 (fr) | 2004-04-15 |
| US20040077703A1 (en) | 2004-04-22 |
| CN1700859A (zh) | 2005-11-23 |
| AU2003279002A1 (en) | 2004-04-23 |
| GEP20084414B (en) | 2008-07-10 |
| EP1545211A1 (fr) | 2005-06-29 |
| EA200500579A1 (ru) | 2005-08-25 |
| WO2004030457A1 (fr) | 2004-04-15 |
| ECSP055736A (es) | 2005-09-20 |
| UA83199C2 (ru) | 2008-06-25 |
| ES2482101T3 (es) | 2014-08-01 |
| HK1072348A1 (en) | 2005-08-26 |
| CR10319A (es) | 2008-10-21 |
| BR0314531A (pt) | 2005-08-09 |
| EA009683B1 (ru) | 2008-02-28 |
| CA2500822C (fr) | 2013-12-24 |
| ZA200502904B (en) | 2005-10-19 |
| MXPA05003581A (es) | 2005-06-17 |
| NZ539227A (en) | 2007-01-26 |
| JP2006502241A (ja) | 2006-01-19 |
| CN100496244C (zh) | 2009-06-10 |
| KR20050059235A (ko) | 2005-06-17 |
| EP1545211B1 (fr) | 2014-04-30 |
| KR20070099668A (ko) | 2007-10-09 |
| AP2047A (en) | 2009-09-18 |
| AP2005003289A0 (en) | 2005-06-30 |
| CR7810A (es) | 2005-05-25 |
| CO5700750A2 (es) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA65277B1 (fr) | Inhibiteurs de l'inflammasome nlrp3 | |
| MA27452A1 (fr) | Derives d'indole servant d'agonistes beta-2 | |
| UY28280A1 (es) | 2- hidroxi - 3- diaminoalcanos de benzamida | |
| MA30342B1 (fr) | Nouvelles compositions pour des troubles capillaires et procede de preparation de celles-ci | |
| MA30722B1 (fr) | Utilisation de derives de l'adenosine en tant qu'agonistes du recepteurs a2a | |
| MA32466B1 (fr) | Derives de triazole utiles pour le traitement de maladies | |
| MXPA04000328A (es) | Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer. | |
| TNSN04151A1 (fr) | Derives de nicotinamide utiles comme inhibiteurs de pde4 | |
| MA27457A1 (fr) | Formulations de derive d'acide nodulisporique pour un traitement cutane localise contre les parasites. | |
| DOP2004001052A (es) | Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1 | |
| MA26997A1 (fr) | Derives de 3-(4-amidopyrrole-2-ylmethylidene)-2-indolinone utilisables comme inhibiteurs de proteine-kinases | |
| TN2009000138A1 (fr) | Biaryl-ether-urees | |
| BR9904998B1 (pt) | derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico e composição farmacêutica. | |
| MA29156B1 (fr) | Procede pour lutter contre des maladies provoquees par des champignons sur des legumineuses | |
| MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
| EA200400595A1 (ru) | Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы | |
| WO2003027068A3 (fr) | Amines substituees pour le traitement de la maladie d'alzheimer | |
| MA35874B1 (fr) | Dérivés d'amide cycliques à utiliser en tant qu'inhibiteurs de 11-bêta-hydroxystéroïde déshydrogénase et utilisations de ceux-ci | |
| MA29554B1 (fr) | Nouveaux derives d'amide d'acide piperidine carboxylique | |
| EE200100513A (et) | Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid | |
| BR9909620A (pt) | Inibidores de metaloproteases de hidroxamato de pirrolidina substituìdo | |
| MA31761B1 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
| MA27135A1 (fr) | Agents antidiabetiques oraux | |
| BR9910494A (pt) | Composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo | |
| MA30313B1 (fr) | Amines secondaires en tant qu'inhibiteurs de la renine |